AMRUTANJAN Intraday Analysis...

AMRUTANJAN Share Price

Open 615.00 Change Price %
High 628.15 1 Day -5.85 -0.95
Low 611.00 1 Week -5.00 -0.81
Close 612.45 1 Month 13.95 2.33
Volume 5901 1 Year -28.10 -4.39
52 Week High 784.20
52 Week Low 530.10
AMRUTANJAN Important Levels
Resistance 2 628.35
Resistance 1 621.80
Pivot 617.20
Support 1 603.10
Support 2 596.55
NSE INDIA Most Active Stocks
RCOM 29.45 0.34%
JPASSOCIAT 21.70 4.08%
GMRINFRA 22.65 -0.44%
VISESHINFO 0.30 0.00%
UNITECH 9.05 2.84%
SUZLON 15.10 1.68%
ITC 274.55 0.42%
ITC 274.55 0.42%
RPOWER 48.90 0.41%
PNB 176.40 3.46%
More..
NSE INDIA Top Gainers Stocks
GSS 38.70 19.26%
GSS 38.70 19.26%
GSS 38.70 19.26%
GSS 38.70 19.26%
GRUH 687.80 15.00%
CYIENT 653.55 12.38%
ORIENTHOT 59.90 11.55%
TTL 122.35 11.38%
PALREDTEC 107.75 11.37%
ZENITHBIR 0.55 10.00%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.35 -12.50%
NAKODA 0.50 -9.09%
SEINV 338.00 -8.78%
INDOTHAI 101.40 -7.86%
DNAMEDIA 9.95 -7.44%
SPYL 0.70 -6.67%
JUBLINDS 249.70 -6.36%
TEJASNET 404.25 -6.32%
RAJRAYON 0.75 -6.25%
UTTAMSUGAR 120.20 -5.69%
More..

Amrutanjan Health Care Limited (NSE: AMRUTANJAN)

AMRUTANJAN Technical Analysis 3
As on 19th Jan 2018 AMRUTANJAN Share Price closed @ 612.45 and we RECOMMEND Sell for LONG-TERM with Stoploss of 630.06 & Sell for SHORT-TERM with Stoploss of 621.99 we also expect STOCK to react on Following IMPORTANT LEVELS.
AMRUTANJAN Target for January
1st Target up-side 714.49
2nd Target up-side 760.25
3rd Target up-side 806.02
1st Target down-side 583.91
2nd Target down-side 538.15
3rd Target down-side 492.38
Amrutanjan Health Care Limited ( NSE INDIA Symbol : AMRUTANJAN )
Sector : Pharmaceuticals - Formulations And Other Stocks in Same Sector
JAGSNPHARM
37.90 -0.40 (-1.04 %)
LT : Buy
ST : Buy
AMRUTANJAN
612.45 -5.85 (-0.95 %)
LT : Sell
ST : Sell
AMRUTANJAN Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 44.41 Sideways
MFI (14) MFI is 61.57 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is 16.32 Range Bound
PSAR Stoploss For Short Sell 667.29
10 Day Avg Volume Traded -55.00 % Less then 10 Day Average Volume
AMRUTANJAN Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals - Formulations
Industry
Offical website
AMRUTANJAN Address
AMRUTANJAN
N/A
AMRUTANJAN Latest News
CRISIL ratings for Indian debt instruments-Mar 17   Reuters   - 17th Mar 15
Director resigns from Amrutanjan Health Care Ltd   Equity Bulls   - 13th Mar 15
Amrutanjan Healthcare Oct—Dec quarter net soars 29.5%   Hindu Business Line   - 05th Feb 15
Amrutanjan Health Care: Board declares interim dividend   Moneycontrol.com   - 05th Feb 15
Buy Amrutanjan Health Care Ltd. with a target of Rs 550: Prakash Gaba   Economic Times   - 08th Dec 14
Amrutanjan Health Care zooms over 50% in three days   Business Standard   - 21st Nov 14
CRISIL ratings for Indian debt instruments-Jan 1   Reuters   - 01st Jan 14
Amrutanjan Health Care (Rs 131): BUY   Hindu Business Line   - 25th Dec 13
Amrutanjan Health Care to split face value of share to   pharmabiz.com   - 11th Oct 12
Buy Amrutanjan Health; target Rs 870: Firstcall Research   Moneycontrol.com   - 08th Oct 12
Interactive Technical Analysis Chart Amrutanjan Health Care Limited ( AMRUTANJAN NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Amrutanjan Health Care Limited
AMRUTANJAN Business Profile
Amrutanjan Health Care Limited started in the year 1893 by the social reformer, journalist and freedom fighter, Desodharaka Sri.Nageswara Rao Pantulu Garu, today Amrutanjan is one of the household names in India.The company’s current offerings have been segregated to 3 sub brands: Kick Out Pain for pain management, Relief for congestion management and Purity for hygiene products. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc.Company is having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Limited having holding stake 99.80% & Amrutanjan Finance Limited, having holding stake is 57.26%. Amrutanjan company has reported a standalone sales of Rs 33.44 crore and a Net Profit of Rs 2.98 crore for the quarter ended September 2013. The Registered office is at No. 103 (Old No.42-45), Luz Church Road, Mylapore, Chennai, Tamil Nadu - 600004.